Scholarlink

<p>This study estimated the economic benefits of robotic-assisted ventral hernia repair (RVHR) using individual patient data (IPD) from a prospective multicenter study, the ASPIRE INDIA. The 30-day quality-adjusted life-years (QALY) gain was estimated from the EuroQol five-dimension three-level questionnaire scores (EQ-5D-3L), with uncertainty quantified via non-parametric bootstrap resampling. Productivity gains were estimated by wages drawn from a lognormal distribution fitted to Periodic Labour Force Survey (PLFS) 2023-24 data, adjusted to FY2026-27. A joint Monte Carlo (MC) simulation propagated uncertainty across all stochastic inputs. The results were scaled to an annual cohort of 300,000 cases. All assumptions were tested through sensitivity analyses. At 300,000 annual cases, the mean total benefit of RVHR over laparoscopic VHR (LVHR) was INR 2,799&#xa0;million (95% confidence interval [CI]: INR 846–5,001) at 1x willingness-to-pay (WTP; INR 210,000/QALY) and INR 2,959&#xa0;million (95% CI: INR 1,010−5,154&#xa0;million) at 2x WTP. Post-anesthesia care unit (PACU) time saved represented the largest component of estimated economic benefit, which accounted for 65.8% of the total benefit at 1x WTP, followed by patient productivity (19.0%), caregiver productivity (9.5%), and QALY gain (5.7%). These findings identify the principal economic benefit dimensions for RVHR and provide a quantitative basis for structured value discussions at the institutional level regarding robotic-assisted surgery (RAS) adoption that should be considered alongside cost data in future comprehensive economic evaluations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Economic benefits of robotic-assisted ventral hernia repair in India: an analysis of health utility, productivity, and operational gains from the real-world ASPIRE INDIA study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月24日

查看全文
  • Randeep Wadhawan,
  • Vivek Bindal,
  • Pradeep Jain,
  • Ashwinikumar Kudari,
  • Sreedhara V. Setty,
  • Kanika Jain,
  • Udipta Ray,
  • Vijaykumar C. Bada,
  • Vishal Soni,
  • Biswabasu Das,
  • Ramkaran Chaudhary,
  • Naveen Sharma,
  • Sudhir Sharma,
  • Akhil Dahiya,
  • Rajveer Bhaskar,
  • Isha Sharma,
  • Prabhakar Pandey,
  • Pradeep Chowbey

摘要

This study estimated the economic benefits of robotic-assisted ventral hernia repair (RVHR) using individual patient data (IPD) from a prospective multicenter study, the ASPIRE INDIA. The 30-day quality-adjusted life-years (QALY) gain was estimated from the EuroQol five-dimension three-level questionnaire scores (EQ-5D-3L), with uncertainty quantified via non-parametric bootstrap resampling. Productivity gains were estimated by wages drawn from a lognormal distribution fitted to Periodic Labour Force Survey (PLFS) 2023-24 data, adjusted to FY2026-27. A joint Monte Carlo (MC) simulation propagated uncertainty across all stochastic inputs. The results were scaled to an annual cohort of 300,000 cases. All assumptions were tested through sensitivity analyses. At 300,000 annual cases, the mean total benefit of RVHR over laparoscopic VHR (LVHR) was INR 2,799 million (95% confidence interval [CI]: INR 846–5,001) at 1x willingness-to-pay (WTP; INR 210,000/QALY) and INR 2,959 million (95% CI: INR 1,010−5,154 million) at 2x WTP. Post-anesthesia care unit (PACU) time saved represented the largest component of estimated economic benefit, which accounted for 65.8% of the total benefit at 1x WTP, followed by patient productivity (19.0%), caregiver productivity (9.5%), and QALY gain (5.7%). These findings identify the principal economic benefit dimensions for RVHR and provide a quantitative basis for structured value discussions at the institutional level regarding robotic-assisted surgery (RAS) adoption that should be considered alongside cost data in future comprehensive economic evaluations.